| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/09/2011 | CA2332115C Aav structural protein, its preparation and use |
| 08/09/2011 | CA2302809C Membrane virus host range mutations and their uses as vaccine substrates |
| 08/09/2011 | CA2267210C Method of stabilizing useful protein and useful protein composition |
| 08/09/2011 | CA2267068C Renilla luciferase and green fluorescent protein fusion genes |
| 08/09/2011 | CA2261158C Prolactin receptor gene as a genetic marker for increased litter size in pigs |
| 08/09/2011 | CA2253240C Hereditary hemochromatosis gene |
| 08/09/2011 | CA2237995C Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them |
| 08/09/2011 | CA2146328C C-c ckr-1, c-c chemokine receptor |
| 08/04/2011 | WO2011094765A2 A targeting signal for integrating proteins, peptides and biological molecules into bacterial microcompartments |
| 08/04/2011 | WO2011094645A1 Methods of diagnosing tau-associated neurodegenerative diseases |
| 08/04/2011 | WO2011093932A2 Design of fibrinogen and fibrinogen derived products with reduced bacterial binding by using modified sequences of fibrinogen chains |
| 08/04/2011 | WO2011093858A1 Cytomegalovirus-based immunogenic preparations |
| 08/04/2011 | WO2011093783A1 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same |
| 08/04/2011 | WO2011093485A1 Method for detection and quantification of hepatitis c virus, and polypeptide for use in the method |
| 08/04/2011 | WO2011092675A2 Molecular complex for targeting antigens towards cells comprising antigens and uses thereof for vaccination |
| 08/04/2011 | WO2011092473A1 Novel compounds and their effects on feeding behaviour |
| 08/04/2011 | WO2011092347A1 Oligopeptidic compounds and uses thereof |
| 08/04/2011 | WO2011092242A1 Factor vii fusion polypeptides |
| 08/04/2011 | WO2011092199A1 Mutated xmrv env proteins in the immunosuppressive domain |
| 08/04/2011 | WO2011091982A1 Process for the purification of glycoproteins |
| 08/04/2011 | WO2011091869A1 Use of low affinity neurotrophin receptor p75 as marker for high differentiation potential muscle stem cells, muscle satellite cells, and degenerative skeletal muscle diseases |
| 08/04/2011 | WO2011091764A1 Genes encoding proteins able to enhance heat resistance of plants and microorganism and uses thereof |
| 08/04/2011 | WO2011091716A1 Epidermal growth factor receptor variant |
| 08/04/2011 | WO2011073208A9 Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin |
| 08/04/2011 | WO2011070214A3 Conjugates and compositions for immunotherapy and anti-tumor treatment |
| 08/04/2011 | WO2011064758A3 Fusion proteins of immunoglobulin fc and interferon- alpha |
| 08/04/2011 | WO2011036564A3 Hyperblebbing shigella strains |
| 08/04/2011 | WO2010115052A3 Induced pluripotent stem cells |
| 08/04/2011 | WO2010045586A8 Muc-1 cytoplasmic domain peptides as inhibitors of cancer |
| 08/04/2011 | US20110191916 Compositions for production of soybean with elevated oil content |
| 08/04/2011 | US20110191912 Promoter, promoter control elements, and combinations, and uses thereof |
| 08/04/2011 | US20110191908 Regulator for flowering time, transgenic plant transformed with the same, and method for regulating flowering time |
| 08/04/2011 | US20110191900 Cry1f and cry1ac transgenic cotton lines and event-specific identification thereof |
| 08/04/2011 | US20110191896 Methods and compositions for increasing plant disease resistance and yield |
| 08/04/2011 | US20110191875 Compositions and methods for making androstenediones |
| 08/04/2011 | US20110191873 Methods of Protein Destabilization and Uses Thereof |
| 08/04/2011 | US20110191865 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 08/04/2011 | US20110190813 Photoactivated crosslinking of a protein or peptide |
| 08/04/2011 | US20110190476 Compositions And Methods For Regulation Of Tumor Necrosis Factor-Alpha |
| 08/04/2011 | US20110190474 Antimicrobial peptides and derived metapeptides |
| 08/04/2011 | US20110190473 Leptin peptide antagonists |
| 08/04/2011 | US20110190224 Non-Viral Delivery of Compounds to Mitochondria |
| 08/04/2011 | US20110190223 Hemcm42 nucleic acids |
| 08/04/2011 | US20110190218 Bag-1 peptide that inhibits prostate cancer |
| 08/04/2011 | US20110190215 Therapeutic use of peptides |
| 08/04/2011 | US20110190210 Prominin-1 peptide fragments and uses thereof |
| 08/04/2011 | US20110190209 Conjugates having a releasable linkage |
| 08/04/2011 | US20110190200 GLUCAGON ANALOGS EXHIBITING ENHANCED SOLUBILITY AND STABILITY IN PHYSIOLOGICAL pH BUFFERS |
| 08/04/2011 | US20110190197 Plant derived antibiotic peptide rich in glycine |
| 08/04/2011 | US20110190195 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 08/04/2011 | US20110190194 Preparation and composition of inter-alpha proteins from blood |
| 08/04/2011 | US20110190168 Apoptosis modulator bcl-b and methods for making and using same |
| 08/04/2011 | US20110190149 Neoepitope detection of disease using protein arrays |
| 08/04/2011 | US20110190144 Novel compositions and methods for the treatment of psoriasis |
| 08/04/2011 | US20110190140 Evolution of whole cells and organisms by recursive sequence recombination |
| 08/04/2011 | US20110189794 Immunoassay with extended detection window |
| 08/04/2011 | US20110189773 Silk fibroin fiber bundles for matrices in tissue engineering |
| 08/04/2011 | US20110189769 Methods and compositions for manipulating the guided navigation of endothelial tubes during angiogenesis |
| 08/04/2011 | US20110189752 Complex |
| 08/04/2011 | US20110189731 Polynucleotides encoding recombinant lubricin molecules and uses thereof |
| 08/04/2011 | US20110189711 Paad domain-containing polypeptides, encoding nucleic acids, and methods of use |
| 08/04/2011 | US20110189652 Viral variants with altered susceptability to nucloeside analogs and uses thereof |
| 08/04/2011 | US20110189651 Method and Device for Detecting Feline Immunodeficiency Virus |
| 08/04/2011 | US20110189479 Formaldehyde-free protein-containing binder compositions |
| 08/04/2011 | US20110189371 Production of canola protein isolate without heat treatment |
| 08/04/2011 | US20110189284 Peptide Fibres |
| 08/04/2011 | US20110189257 Nanoparticle based therapy for aggregating mucin |
| 08/04/2011 | US20110189238 Use of a soluble form of hla-g in the treatment of abnormal b-lymphocyte proliferation |
| 08/04/2011 | US20110189233 Recombinant Varicella-Zoster Virus |
| 08/04/2011 | US20110189230 Vaccination with multiple clades of h5 influenza a virus |
| 08/04/2011 | US20110189228 Production of Heterologous Polypeptides in Microalgae, Microalgal Extracellular Bodies, Compositions, and Methods of Making and Uses Thereof |
| 08/04/2011 | US20110189225 Attenuated bacteria useful in vaccines |
| 08/04/2011 | US20110189221 Novel antiviral compounds from marine extracts |
| 08/04/2011 | US20110189214 Cdca1 epitope peptides and vaccines containing the same |
| 08/04/2011 | US20110189207 Methods for soluble zalpha11 cytokine receptors |
| 08/04/2011 | US20110189206 Antibody Targeting Through a Modular Recognition Domain |
| 08/04/2011 | US20110189205 Methods of treating cancer using an agent that modulates activity of the calcitonin-gene related peptide ("cgrp") receptor |
| 08/04/2011 | US20110189202 Compositions comprising soluble cd84 or anti-cd84 antibodies and methods for diagnosing and treating b-cll |
| 08/04/2011 | US20110189199 Methods for p2ry5 mediated regulation of hair growth and mutants thereof |
| 08/04/2011 | US20110189196 Metal-citrate transporter antigen from streptomyces coelicolor and uses thereof |
| 08/04/2011 | US20110189188 Novel gp96 derived peptides |
| 08/04/2011 | US20110189187 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/04/2011 | US20110189181 Use of agents derived from CEACAM1 for the treatment of inflammatory diseases |
| 08/04/2011 | US20110189180 Antigenic compositions and use of same in the targeted delivery of nucleic acids |
| 08/04/2011 | US20110189168 Antibody-induced apoptosis |
| 08/04/2011 | US20110189164 Peptide Stabilizer Compounds and Screening Method |
| 08/04/2011 | US20110189159 Methods and compositions for protein delivery |
| 08/04/2011 | US20110189139 Hematopoietic Cell E-Selectin/L-Selectin Ligand Glycosylated CD44 Polypeptide |
| 08/04/2011 | US20110189131 Active variants of the il-18 binding protein and medical uses thereof |
| 08/04/2011 | US20110189128 Recombinant super-compound interferon |
| 08/04/2011 | US20110189124 Methods for refolding proteins containing free cysteine residues |
| 08/04/2011 | US20110189123 Mammalian cx3c chemokine antibodies |
| 08/04/2011 | US20110189120 Aegyptin and uses thereof |
| 08/04/2011 | US20110189105 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 08/04/2011 | US20110189097 Use of WNT inhibitor to inhibit angiogenesis in the CNS |
| 08/04/2011 | US20110189095 Crkl targeting peptides |
| 08/04/2011 | US20110189084 Method for Treating Liver Disorders with Receptor Associated Protein (RAP) Peptide-Fucosidase Inhibitor Conjugates |
| 08/04/2011 | CA2825282A1 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same |
| 08/04/2011 | CA2788726A1 Oligopeptidic compounds and uses thereof |
| 08/04/2011 | CA2788013A1 Novel compounds and their effects on feeding behaviour |